Schrodinger, Inc. (SDGR): Depreciation & Amortization
$6.02M
Year ended 2025-12-31
$5.87M
Trailing 12 months to 2026-06-30
+11.5%
3-year compound annual growth
+10.5%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.02M | -2.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $6.16M | +10.9% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $5.55M | +27.8% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $4.34M | +52.6% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $2.85M | -22.2% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $3.66M | +0.5% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $3.64M | n/a | 2022-02-24, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $10.00M | 0.0% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $33.77M | -4.2% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $559.0K | -7.8% |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $10.94M | -5.1% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $1.31M | +7.0% |
Compare SDGR, ARVN, RCUS, LGND side by side · Screen every company in Pharmaceutical Preparations ↗